Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes.
暂无分享,去创建一个
M. Reilly | D. Rader | N. Mehta | A. Menter | C. Ryan | J. Schussler | D. Kivelevitch | B. Mansouri | A. Joshi | Katie E Benjegerdes | B. Natarajan
[1] H. Bøtker,et al. Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis. , 2015, The American journal of medicine.
[2] D. Bluemke,et al. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. , 2015, European heart journal.
[3] T. Torres,et al. Epicardial adipose tissue and coronary artery calcification in psoriasis patients , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] I. Benseñor,et al. Association between psoriasis and coronary calcium score. , 2014, Atherosclerosis.
[5] D. Margolis,et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study , 2014, Annals of the rheumatic diseases.
[6] S. Younespour,et al. Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: is psoriasis associated with atherosclerosis? , 2014, Journal of the American Academy of Dermatology.
[7] D. Bluemke,et al. Vascular inflammation in psoriasis localizes to the arterial wall using a novel imaging technique. , 2014, Journal of the American Academy of Dermatology.
[8] M. Budoff,et al. Coronary computed tomography as a cost-effective test strategy for coronary artery disease assessment - a systematic review. , 2014, Atherosclerosis.
[9] E. Mohler,et al. Endothelial Cell‐, Platelet‐, and Monocyte/Macrophage‐Derived Microparticles are Elevated in Psoriasis Beyond Cardiometabolic Risk Factors , 2014, Journal of the American Heart Association.
[10] M. Reilly,et al. Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors , 2014, Clinical and experimental dermatology.
[11] L. Arends,et al. Markers of systemic inflammation in psoriasis: a systematic review and meta‐analysis , 2013, The British journal of dermatology.
[12] Jashin J. Wu,et al. Association of ethnicity, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis. , 2013, Journal of the American Academy of Dermatology.
[13] A. Armstrong,et al. Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies , 2013, Journal of the American Heart Association.
[14] A. Armstrong,et al. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. , 2013, Journal of the American Academy of Dermatology.
[15] C. Siu,et al. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis , 2013, Journal of internal medicine.
[16] Rosa Parisi,et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.
[17] J. Tardif,et al. Effects of the Tumor Necrosis Factor-&agr; Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis: Results of a Randomized Controlled Trial , 2013, Circulation. Cardiovascular imaging.
[18] A. Armstrong,et al. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies , 2012, Nutrition & Diabetes.
[19] M. Reilly,et al. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. , 2012, Atherosclerosis.
[20] David J. Margolis,et al. Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom , 2011, The Journal of investigative dermatology.
[21] A. Alavi,et al. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. , 2011, Archives of dermatology.
[22] A. Troxel,et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. , 2011, The American journal of medicine.
[23] P. Greenland,et al. Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. , 2011, Journal of the American College of Cardiology.
[24] D. Federman,et al. Psoriasis and Vascular Disease—Risk Factors and Outcomes: A Systematic Review of the Literature , 2011, Journal of General Internal Medicine.
[25] C. Apovian,et al. Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and Promotes Inflammation in Type 2 Diabetes , 2011, The Journal of Immunology.
[26] M. Budoff,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[27] A. Troxel,et al. Cause‐specific mortality in patients with severe psoriasis: a population‐based cohort study in the U.K. , 2010, The British journal of dermatology.
[28] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.
[29] P. Greenland,et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.
[30] Andrea B Troxel,et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. , 2010, European heart journal.
[31] A. Troxel,et al. The risk of stroke in patients with psoriasis. , 2009, The Journal of investigative dermatology.
[32] D. Federman,et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. , 2009, Archives of dermatology.
[33] K. Ley,et al. Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.
[34] C. Becker,et al. Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: A prospective study in 716 patients over 8 years , 2008, BMC cardiovascular disorders.
[35] S. Humphries,et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. , 2008, European heart journal.
[36] Steven R Feldman,et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. , 2008, Journal of the American Academy of Dermatology.
[37] R. Kronmal,et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.
[38] C. Herzog,et al. Psoriasis: a possible risk factor for development of coronary artery calcification , 2007, The British journal of dermatology.
[39] Daniel B. Shin,et al. Prevalence of cardiovascular risk factors in patients with psoriasis. , 2006, Journal of the American Academy of Dermatology.
[40] D. Margolis,et al. Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.
[41] L. Shaw,et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. , 2006, European heart journal.
[42] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[43] A. Localio,et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.
[44] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[45] R. Seibel,et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. , 1997, Journal of the American College of Cardiology.
[46] S. Nomura,et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. , 1995, Atherosclerosis.
[47] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[48] P. Calabresi,et al. Psoriasis and occlusive vascular disease , 1978, The British journal of dermatology.
[49] J. Tobin. Estimation of Relationships for Limited Dependent Variables , 1958 .